As of January 22, 2025, Acumen Pharmaceuticals (ABOS) has a market cap of $0.11 billion USD. According to our data, Acumen Pharmaceuticals is ranked No.7654 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.11 B |
1.74%
|
Dec 31, 2024 | $0.10 B |
-55.21%
|
Dec 29, 2023 | $0.23 B |
-28.89%
|
Dec 30, 2022 | $0.32 B |
-20.12%
|
Dec 31, 2021 | $0.41 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Catalyst Pharmaceuticals
CPRX
|
$2.73 B |
0.000 M
|
USA
|
Market Cap | = | ABOS Stock Price | * | ABOS Shares Outstanding |
= | $1.75 | * | 60.08 M | |
= | $0.11 B |